U.S. markets closed

Genocea Biosciences, Inc. (GNCA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5300-0.0600 (-2.32%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/11/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
140.99M147.34M128.31M118.08M68.92M47.55M
Enterprise Value 3
94.60M91.44M65.44M121.83M68.65M28.04M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
110.6892.8365.1570.64N/AN/A
Price/Book (mrq)
80.0116.406.3514.695.601.90
Enterprise Value/Revenue 3
69.61N/AN/A268.9375.77N/A
Enterprise Value/EBITDA 7
-2.35-8.08-4.57-31.50-6.43-2.28

Trading Information

Stock Price History

Beta (5Y Monthly) 1.63
52-Week Change 38.58%
S&P500 52-Week Change 338.51%
52 Week High 35.7500
52 Week Low 31.7400
50-Day Moving Average 32.4044
200-Day Moving Average 32.6371

Share Statistics

Avg Vol (3 month) 3326.85k
Avg Vol (10 day) 3202.77k
Shares Outstanding 554.43M
Implied Shares Outstanding 6N/A
Float 27.36M
% Held by Insiders 18.86%
% Held by Institutions 159.50%
Shares Short (May 27, 2021) 41.63M
Short Ratio (May 27, 2021) 47.88
Short % of Float (May 27, 2021) 43.70%
Short % of Shares Outstanding (May 27, 2021) 42.99%
Shares Short (prior month Apr 29, 2021) 41.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 21, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3May 21, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,387.49%

Management Effectiveness

Return on Assets (ttm)-44.56%
Return on Equity (ttm)-579.95%

Income Statement

Revenue (ttm)1.36M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.36M
EBITDA -45.39M
Net Income Avi to Common (ttm)-42.84M
Diluted EPS (ttm)-0.9420
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.03M
Total Cash Per Share (mrq)1.21
Total Debt (mrq)19.64M
Total Debt/Equity (mrq)1,114.87
Current Ratio (mrq)6.02
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-40.25M
Levered Free Cash Flow (ttm)-27.59M